Tomography News and Research

RSS

Technological breakthrough allows U-M Health System to reduce patients' radiation exposure

A technological breakthrough is allowing the University of Michigan Health System to be the first teaching hospital in the U.S. to perform some CT scans using a fraction of the radiation dose required for a conventional CT image.

20 Jan 2012

Novelos initiates enrollment in HOT Phase 1b trial for advanced solid tumors

Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that it has enrolled the first patient in a U.S. multi-center Phase 1b dose-escalation trial of its cancer-targeted molecular radiotherapeutic compound (131)I-CLR1404 (HOT) in cancer patients with advanced solid tumors.

18 Jan 2012

Traditional autopsy is still the gold standard in determining cause of death

TV crime shows like Bones and CSI are quick to explain each death by showing highly detailed scans and video images of victims' insides. Traditional autopsies, if shown at all, are at best in supporting roles to the high-tech equipment, and usually gloss over the sometimes physically grueling tasks of sawing through skin and bone.

17 Jan 2012

Drinking alcohol leads to release of endorphins in the brain

Drinking alcohol leads to the release of endorphins in areas of the brain that produce feelings of pleasure and reward, according to a study led by researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco.

12 Jan 2012

Insurance status does not affect quantity of imaging services received by hospital in-patients

Insurance status doesn't affect the quantity (or value) of imaging services received by patients in a hospital, in-patient setting, according to a study in the January issue of the Journal of the American College of Radiology.

7 Jan 2012

VisionGate achieves full automation of Cell-CT system

VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer and other applications, today reported that it has achieved full automation of its Cell-CT system, a proprietary imaging platform that generates high-resolution 3D biosignatures from intact cells.

7 Jan 2012

FDG-PET safe and accurate in detecting dementia, Alzheimer's

In a new review of imaging studies spanning more than ten years, scientists find that a method of positron emission tomography (PET) safely and accurately detects dementia, including the most common and devastating form among the elderly, Alzheimer's disease.

7 Jan 2012

Article summarizes methods for radiation dose optimization in pediatric CT scans

An article in the January issue of the Journal of the American College of Radiology summarizes methods for radiation dose optimization in pediatric computed tomography (CT) scans.

6 Jan 2012

New imaging technology may pinpoint subtle aberrations in molecular biosignature of cancer

Despite advances in both the diagnosis and treatment of breast cancer, the disease remains a leading worldwide health concern.

6 Jan 2012

FDA clears OptiMedica's Catalys Precision Laser System

Global ophthalmic company OptiMedica Corp. has announced the U.S. Food and Drug Administration (FDA) 510(k) market clearance of its Catalys Precision Laser System, a next generation laser cataract surgery system that brings unequaled precision and accuracy and a markedly streamlined workflow to the laser cataract procedure.

22 Dec 2011

FLT-PET imaging can effectively detect mantle cell lymphoma

Positron emission tomography (PET) and a molecular imaging agent that captures the proliferation of cancer cells could prove to be a valuable method for imaging a form of Non-Hodgkin's disease called mantle cell lymphoma, a relatively rare and devastating blood cancer.

22 Dec 2011

FDA approves Infrascanner to detect life-threatening brain bleeding

Battlefield corpsmen and medical professionals across the country gained a valuable tool last week, as the Food and Drug Administration approved the first hand-held device to detect life-threatening bleeding in the brain.

22 Dec 2011

Optical coherence tomography measures changes in retinal cone cells

Humans see color thanks to cone cells, specialized light-sensing neurons located in the retina along the inner surface of the eyeball. The actual light-sensing section of these cells is called the outer segment, which is made up of a series of stacked discs, each about 30 nanometers (billionths of a meter) thick. This appendage goes through daily changes in length.

21 Dec 2011

IASLC takes proactive role in advancing lung cancer screening forward

The International Association for the Study of Lung Cancer (IASLC) has taken a proactive role in advancing discussions with the international lung cancer community on how we should take lung cancer screening forward.

16 Dec 2011

Metabolomx' colorimetric sensor array can identify subtype of lung cancer

Metabolomx, a diagnostic company focused on the detection of the metabolomics signature of cancer from exhaled breath, today announces publication of results from the first clinical study demonstrating a breath test that can both detect lung cancer and differentiate between types of lung cancer in humans.

16 Dec 2011

Decision support tool for objective diagnostics of Alzheimer's

European PredictAD project, lead by Principal Scientist Jyrki Lötjönen from VTT Technical Research Centre of Finland, has developed a decision support tool for objective diagnostics of Alzheimer's disease.

15 Dec 2011

Multiple CT scans can increase risk of cancer

From the doctor's office to the airport, Americans have more opportunity for radiation exposure than ever before. While low levels of radiation are used in medical imaging and airport body scanners, there is much debate about exposure levels and potential cancer risks. New research from Wake Forest Baptist Medical Center has found that there could be an increased risk of cancer for certain individuals who are exposed to multiple CT scans.

15 Dec 2011

Health Canada approves Positron's Attrius system

Positron Corporation, a leading molecular imaging company specializing in the field of nuclear cardiology is pleased to announce today that on December 12, 2011, the Company's Positron Emission Tomography Scanner(s) Attrius & Attrius L have received approval for sale in Canada.

15 Dec 2011

FDA allows marketing of Infrascanner Model 1000 for intracranial hematomas diagnosis

The U.S. Food and Drug Administration today allowed marketing of the first hand-held device intended to aid in the detection of life-threatening bleeding in the skull called intracranial hematomas, using near-infrared spectroscopy.

14 Dec 2011

PET scans can provide insight into process that causes aortic stenosis

Patients with life-threatening heart valve disease could be helped with alternative scanning techniques that provide greater insight into the condition.

13 Dec 2011